登录
免费注册
首页
论文
论文详情
赞
收藏
引用
分享
科研之友
微信
新浪微博
Facebook
分享链接
A Phase 1 Study of CAL-101, An Isoform-Selective Inhibitor of Phosphatidylinositol 3-Kinase P110 delta, In Combination with Rituximab and/or Bendamustine In Patients with Relapsed or Refractory B-Cell Malignancies
作者:Flinn Ian W; Schreeder Marshall T; Wagner Johnston Nina; Boccia Ralph V; Leonard John P; Coutre Steven E; Holes Leanne M; Peterman Sissy; Yu Albert S
来源:
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
, 2010-12-04 to 2010-12-07.
出版日期
2010-11-19
相似论文
引用论文
参考文献